ANIK Insider Trading Activity and SEC Form 4 Filings
ANIK insider trading summary
Over the past 12 months, insiders at Anika Therapeutics, Inc. (ANIK) reported 4 open-market purchases worth $264K by 3 insiders and no sales on SEC Form 4. Net insider buying was $264K.
Latest ANIK insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 4, 2026 | Gary P Fischetti | Insider | Buy | $20K (1,000 @ $20.32) |
| Aug 3, 2026 | Gary P Fischetti | Insider | Buy | $21K (1,000 @ $20.75) |
| May 1, 2026 | John B Henneman III | Insider | Buy | $73K (5,000 @ $14.66) |
| Apr 30, 2026 | Stephen D. Griffin | President and CEO | Buy | $150K (12,200 @ $12.29) |
| May 11, 2022 | David Colleran | EVP, General Counsel, Corp Sec | Buy | $32K (1,500 @ $21.37) |
| Mar 14, 2022 | David Colleran | EVP, General Counsel, Corp Sec | Buy | $40K (1,500 @ $26.65) |
| Mar 11, 2022 | Cheryl R Blanchard | President, CEO, Director | Buy | $109K (4,287 @ $25.36) |
| Mar 11, 2022 | Cheryl R Blanchard | President, CEO, Director | Buy | $98K (3,813 @ $25.81) |
| Mar 11, 2022 | Jeffery S Thompson | Director | Buy | $49K (2,000 @ $24.66) |
| Mar 11, 2022 | Michael L Levitz | EVP, CFO, Treasurer | Buy | $98K (4,000 @ $24.62) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.